Literature DB >> 23561088

Maqui berry (Aristotelia chilensis) and the constituent delphinidin glycoside inhibit photoreceptor cell death induced by visible light.

Junji Tanaka1, Takashi Kadekaru, Kenjirou Ogawa, Shoketsu Hitoe, Hiroshi Shimoda, Hideaki Hara.   

Abstract

The protective effects of maqui berry (Aristotelia chilensis) extract (MBE) and its major anthocyanins [delphinidin 3,5-O-diglucoside (D3G5G) and delphinidin 3-O-sambubioside-5-O-glucoside (D3S5G)] against light-induced murine photoreceptor cells (661W) death were evaluated. Viability of 661W after light treatment for 24 h, assessed by the tetrazolium salt (WST-8) assay and Hoechst 33342 nuclear staining, was improved by addition of MBE, D3G5G, and D3S5G. Intracellular radical activation in 661W, evaluated using the reactive oxygen species (ROS)-sensitive probe 5-(and-6)-chloromethyl-2,7-dichlorodihydro fluorescein diacetate acetyl ester (CM-H2DCFDA), was reduced by MBE and its anthocyanins. The anti-apoptosis mechanism of MBE was evaluated by light-induced phosphorylation of p38. MBE significantly suppressed the light-induced phosphorylation of p38. These findings indicate that MBE and its anthocyanidins suppress the light-induced photoreceptor cell death by inhibiting ROS production, suggesting that the inhibition of phosphorylated-p38 may be involved in the underlying mechanism.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23561088     DOI: 10.1016/j.foodchem.2013.01.036

Source DB:  PubMed          Journal:  Food Chem        ISSN: 0308-8146            Impact factor:   7.514


  8 in total

Review 1.  The transcorneal electrical stimulation as a novel therapeutic strategy against retinal and optic neuropathy: a review of experimental and clinical trials.

Authors:  Ye Tao; Tao Chen; Bei Liu; Li-Qiang Wang; Guang-Hua Peng; Li-Min Qin; Zhong-Jun Yan; Yi-Fei Huang
Journal:  Int J Ophthalmol       Date:  2016-06-18       Impact factor: 1.779

Review 2.  Anthocyanin can arrest the cone photoreceptor degeneration and act as a novel treatment for retinitis pigmentosa.

Authors:  Ye Tao; Tao Chen; Guo-Qing Yang; Guang-Hua Peng; Zhong-Jun Yan; Yi-Fei Huang
Journal:  Int J Ophthalmol       Date:  2016-01-18       Impact factor: 1.779

3.  Photoprotective effects of cranberry juice and its various fractions against blue light-induced impairment in human retinal pigment epithelial cells.

Authors:  Chi-Huang Chang; Hui-Fang Chiu; Yi-Chun Han; I-Hsien Chen; You-Cheng Shen; Kamesh Venkatakrishnan; Chin-Kun Wang
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

4.  Effects of MaquiBright® on improving eye dryness and fatigue in humans: A randomized, double-blind, placebo-controlled trial.

Authors:  Shin-Ichiro Yamashita; Naoko Suzuki; Kazuo Yamamoto; Shin-Ichiro Iio; Takahiro Yamada
Journal:  J Tradit Complement Med       Date:  2018-11-22

Review 5.  The Protective Effects of Flavonoids in Cataract Formation through the Activation of Nrf2 and the Inhibition of MMP-9.

Authors:  Aaron Hilliard; Patricia Mendonca; Tanya D Russell; Karam F A Soliman
Journal:  Nutrients       Date:  2020-11-27       Impact factor: 5.717

Review 6.  Can Nutrition Play a Role in Ameliorating Digital Eye Strain?

Authors:  Drake W Lem; Dennis L Gierhart; Pinakin Gunvant Davey
Journal:  Nutrients       Date:  2022-09-27       Impact factor: 6.706

7.  Bilberry extract and anthocyanins suppress unfolded protein response induced by exposure to blue LED light of cells in photoreceptor cell line.

Authors:  Emi Ooe; Yoshiki Kuse; Tomohiro Yako; Tetsuya Sogon; Shinsuke Nakamura; Hideaki Hara; Masamitsu Shimazawa
Journal:  Mol Vis       Date:  2018-09-24       Impact factor: 2.367

Review 8.  Exploring the Applications of the Photoprotective Properties of Anthocyanins in Biological Systems.

Authors:  Hélder Oliveira; Patrícia Correia; Ana Rita Pereira; Paula Araújo; Nuno Mateus; Victor de Freitas; Joana Oliveira; Iva Fernandes
Journal:  Int J Mol Sci       Date:  2020-10-10       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.